This is a representational image (Pic credit: Lexica)
HYDERABAD: Pharma major Dr Reddy’s Laboratories on Tuesday reported a 15% drop in consolidated net profit for the Sept quarter, despite its quarterly revenues surpassing the Rs 8,000-crore mark for the first time, primarily due to price erosion in the US generic market. Consolidated net profit for Q2 fell to Rs 1,255 crore from Rs 1,480 crore a year ago.
